Esophageal Diseases  >>  irinotecan  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
irinotecan / Generic mfg.
ITACA-S, NCT01640782: Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach

Completed
3
1100
Europe
Irinotecan, Leucovorin, 5-Fluorouracil, Docetaxel, Cisplatin, Leucovorin, 5-Fluorouracil
Mario Negri Institute for Pharmacological Research, Aventis Pharmaceuticals, Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente, Gruppo Oncologico Italiano di Ricerca Clinica, Gruppo Oncologico del Nord-Ovest, Italian Trial in Medical Oncology, Southern Italy Cooperative Oncology Group, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Oncotech
Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction
01/13
01/13
NCT00160875: Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer

Completed
2/3
54
Canada
Irinotecan hydrochloride trihydrate, Cisplatin
University Health Network, Toronto, Pfizer
Esophageal Cancer
03/11
03/11

Download Options